Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for implantable automatic defibrillators: critical analysis].

O Thomas1, F Extramiana, P Milliez

  • 1Service de cardiologie, hôpital Lariboisière, 2, rue Ambroise-Paré, 75475 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of pre-eclampsia according to gestational age across three decades: population-based study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Factors associated with increased radiation exposure in the fixation of proximal femoral fractures.

Annals of the Royal College of Surgeons of England·2024
Same author

Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey.

Journal of neurology·2024
Same author

In silico interrogation of the miRNAome of infected hematopoietic cells to predict processes important for human cytomegalovirus latent infection.

The Journal of biological chemistry·2023
Same author

Bragg coherent diffraction imaging of single 20 nm Pt particles at the ID01-EBS beamline of ESRF.

Journal of applied crystallography·2022
Same author

Effect of type 1 tympanoplasty on the quality of life of patients suffering from chronic otitis media (safe type).

Nigerian journal of clinical practice·2021
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Implantable automatic defibrillators (IADs) are revolutionizing arrhythmia management. Recent studies show IADs improve survival for primary prevention and severe ventricular arrhythmias, suggesting increased future use.

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Background:

  • Malignant ventricular arrhythmias pose significant risks.
  • Implantable automatic defibrillators (IADs) offer a crucial treatment option.
  • Current IAD adoption in France is limited by cost and awareness.

Purpose of the Study:

  • To review the current status and future prospects of IADs.
  • To highlight the impact of recent clinical trials on IAD indications.
  • To address factors influencing IAD implantation rates.

Main Methods:

  • Review of clinical trial data (MADIT, MUSTT, MADIT II, AVID, CIDS, CASH).
  • Analysis of factors affecting IAD adoption.
  • Discussion of technological advancements in IAD implantation.

Related Experiment Videos

Main Results:

  • IADs are effective for patients with drug-resistant arrhythmias.
  • Prophylactic IAD implantation is validated for primary prevention post-infarction.
  • IADs demonstrate superior survival rates compared to antiarrhythmic drugs in severe cases.

Conclusions:

  • IAD technology has advanced significantly, simplifying implantation.
  • Evidence supports expanded IAD use for primary and secondary prevention of sudden cardiac death.
  • Increased awareness and improved reimbursement are expected to drive future IAD adoption.